Menveo Kit
Product Images NDC 58160-955

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Menveo (NDC 58160-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Menveo Figure 1 (Menveo Spl Graphic 01)

MenCYW-135 is a liquid conjugate component.*

FDA Label Image

Menveo Figure 2 (Menveo Spl Graphic 02)

FDA Label Image

Menveo Figure 3 (Menveo Spl Graphic 03)

FDA Label Image

Menveo Figure 4 (Menveo Spl Graphic 04)

FDA Label Image

Menveo Carton (Menveo Spl Graphic 05)

This is a description of MENVEO, a meningococcal vaccine that combines two components, MenGYW-135 liquid conjugate component and MenA lyophilized conjugate component, before use. It contains the oligosaccharide diphtheria CRM,q; conjugate vaccine and is intended for use in people aged 2 months through 55 years old. Each package includes 5 vials of MenCYW-135 liquid conjugate component and 5 vials of MenA lyophilized conjugate component, containing 5 doses of the vaccine. Once reconstituted, a single dose of MENVEO is 0.5 mL.*

FDA Label Image

Menveo Mena Vial Label (Menveo Spl Graphic 06)

This is a product label for a vial from GSK Vaccines with the lot number NOC 58160-958-01. There is no additional information available.*

FDA Label Image

Menveo Mencyw-135 Vial Label (Menveo Spl Graphic 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.